SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
28.94
-0.05 (-0.17%)
Sep 4, 2026, 4:00 PM EDT - Market closed
SpyGlass Pharma Employees
SpyGlass Pharma had 76 employees as of June 30, 2026.
Employees
76
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$737,539
Market Cap
967.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 76 | - | - |
| Mar 31, 2026 | 68 | - | - |
| Dec 31, 2025 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Wave Life Sciences | 317 |
| Geron | 258 |
| Olema Pharmaceuticals | 150 |
| Adlai Nortye Group | 109 |
| Annexon | 92 |
| Lexicon Pharmaceuticals | 81 |
| Crescent Biopharma | 69 |
SGP News
- 5 days ago - SpyGlass Pharma to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 22 days ago - SpyGlass Pharma initiated with an Outperform at Raymond James - TheFly
- 4 weeks ago - SpyGlass Pharma reports Q2 EPS (59c), consensus (55c) - TheFly
- 4 weeks ago - SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 4 weeks ago - SpyGlass Pharma Earnings release: Q2 2026 - Filings
- 4 weeks ago - SpyGlass Pharma Quarterly report: Q2 2026 - Filings
- 2 months ago - SpyGlass Pharma Appoints Shannon Treviño as General Counsel - GlobeNewsWire
- 2 months ago - SpyGlass Pharma Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts